Martin Schaefer

6.2k total citations
71 papers, 2.3k citations indexed

About

Martin Schaefer is a scholar working on Epidemiology, Psychiatry and Mental health and Hepatology. According to data from OpenAlex, Martin Schaefer has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Psychiatry and Mental health and 18 papers in Hepatology. Recurrent topics in Martin Schaefer's work include Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (16 papers) and Tryptophan and brain disorders (15 papers). Martin Schaefer is often cited by papers focused on Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (16 papers) and Tryptophan and brain disorders (15 papers). Martin Schaefer collaborates with scholars based in Germany, United States and United Kingdom. Martin Schaefer's co-authors include Andreas Heinz, Heinz Grunze, Folkhard Schmidt, Axel Hinzpeter, Markus Backmund, Klaus Lieb, Astrid Friebe, Markus Schwaiger, M.G.L. Pich and Stefan Mauss and has published in prestigious journals such as NeuroImage, Hepatology and Cancer Research.

In The Last Decade

Martin Schaefer

67 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Schaefer Germany 25 1.1k 1.0k 468 401 216 71 2.3k
James R. Spivey United States 25 1.1k 1.0× 1.0k 1.0× 299 0.6× 866 2.2× 665 3.1× 55 3.1k
Michael R. Kraus Germany 22 770 0.7× 753 0.7× 225 0.5× 269 0.7× 157 0.7× 53 1.6k
Daniel Forton United Kingdom 22 1.7k 1.6× 1.5k 1.4× 261 0.6× 247 0.6× 90 0.4× 53 2.4k
Geert Robaeys Belgium 22 1.2k 1.1× 1.2k 1.2× 238 0.5× 558 1.4× 398 1.8× 94 2.1k
Eric Dieperink United States 22 1.2k 1.1× 1.2k 1.1× 191 0.4× 218 0.5× 117 0.5× 36 1.7k
Andrey Borisov United States 14 266 0.2× 1.0k 1.0× 205 0.4× 551 1.4× 413 1.9× 25 2.1k
F Grünhage Germany 27 877 0.8× 1.1k 1.1× 386 0.8× 36 0.1× 41 0.2× 87 2.8k
Tae Suk Kim South Korea 21 270 0.2× 340 0.3× 147 0.3× 112 0.3× 66 0.3× 56 1.6k
Bruce H. Phelps United States 21 638 0.6× 766 0.7× 277 0.6× 87 0.2× 15 0.1× 42 1.7k
Vı́ctor Navarro Spain 22 132 0.1× 263 0.3× 248 0.5× 75 0.2× 31 0.1× 64 1.6k

Countries citing papers authored by Martin Schaefer

Since Specialization
Citations

This map shows the geographic impact of Martin Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schaefer more than expected).

Fields of papers citing papers by Martin Schaefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schaefer. The network helps show where Martin Schaefer may publish in the future.

Co-authorship network of co-authors of Martin Schaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Schaefer. A scholar is included among the top collaborators of Martin Schaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Schaefer. Martin Schaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cramer, Holger, et al.. (2023). Chlormethiazole as a hypnotic in elderly patients: A systematic review and meta‐analysis. Journal of Sleep Research. 33(2). e14018–e14018.
2.
Sarkar, Rahul, Astrid Friebe, Ulrich Spengler, et al.. (2021). Influence of gender on cytokine induced depression and treatment. Journal of Affective Disorders. 292. 766–772. 2 indexed citations
3.
Engel, Katharina, et al.. (2015). The Role of Psychological Distress in Relapse Prevention of Alcohol Addiction. Can High Scores on the SCL-90-R Predict Alcohol Relapse?. Alcohol and Alcoholism. 51(1). 27–31. 24 indexed citations
4.
Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy. 26(10). 1028–1038. 135 indexed citations
5.
Robaeys, Geert, Jason Grebely, Stefan Mauss, et al.. (2013). Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical Infectious Diseases. 57(suppl 2). S129–S137. 86 indexed citations
6.
Richter, Christoph, Tom Bschor, Udo Bonnet, et al.. (2012). Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients. Journal of Clinical Psychopharmacology. 32(4). 558–562. 21 indexed citations
7.
Friebe, Astrid, et al.. (2010). Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant Melanoma. Psychosomatics. 51(6). 466–473. 34 indexed citations
8.
Richter, Christoph, Axel Hinzpeter, Folkhard Schmidt, et al.. (2010). Levetiracetam for the Treatment of Alcohol Withdrawal Syndrome. Journal of Clinical Psychopharmacology. 30(6). 720–725. 19 indexed citations
9.
Schaefer, Martin, Jochen Winterer, Rahul Sarkar, et al.. (2008). Three Cases of Successful Tryptophan Add-On or Monotherapy of Hepatitis C and IFNα-Associated Mood Disorders. Psychosomatics. 49(5). 442–446. 12 indexed citations
10.
Schaefer, Martin & Stefan Mauss. (2008). Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects. Current Drug Abuse Reviews. 1(2). 177–187. 38 indexed citations
11.
Schaefer, Martin, Axel Hinzpeter, M.G.L. Pich, et al.. (2007). Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin. Hepatology. 46(4). 991–998. 113 indexed citations
12.
Schaefer, Martin, Markus Schwaiger, M.G.L. Pich, et al.. (2005). Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. Journal of Hepatology. 42(6). 793–798. 139 indexed citations
13.
Schaefer, Martin, Andreas Heinz, & Markus Backmund. (2004). Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?. Addiction. 99(9). 1167–1175. 85 indexed citations
14.
Schiemann, U, Jürgen Glas, Kathleen Martin, et al.. (2003). Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism. Digestion. 68(1). 1–4. 20 indexed citations
15.
Glas, Jürgen, Helga‐Paula Török, August König, et al.. (2003). The Δ32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-α and ribavirin. Clinical Immunology. 108(1). 46–50. 23 indexed citations
16.
Schaefer, Martin, Oliver Gut, Bernd L. Fiebich, et al.. (2002). Interferon alpha (IFNα) and psychiatric syndromes. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(4). 731–746. 150 indexed citations
17.
Doenst, Torsten, Michael Berchtold‐Herz, Koppany Sarai, et al.. (2001). Left Ventricular Reduction for Idiopathic Dilated Cardiomyopathy as Alternative to Transplant - Truth or Dare?*. The Thoracic and Cardiovascular Surgeon. 49(2). 70–74. 8 indexed citations
18.
Schaefer, Martin & H. Siebert. (2000). Finger- und Mittelhandfrakturen. Der Unfallchirurg. 103(7). 582–592. 1 indexed citations
19.
Akaike, Takaaki, Eberhard Weihe, Martin Schaefer, et al.. (1995). Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. Journal of NeuroVirology. 1(1). 118–125. 73 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Spivey Breakdown of academic impact, for papers by Michael R. Kraus Breakdown of academic impact, for papers by Daniel Forton Breakdown of academic impact, for papers by Geert Robaeys Breakdown of academic impact, for papers by Eric Dieperink Breakdown of academic impact, for papers by Andrey Borisov Breakdown of academic impact, for papers by F Grünhage Breakdown of academic impact, for papers by Tae Suk Kim Breakdown of academic impact, for papers by Bruce H. Phelps Breakdown of academic impact, for papers by Vı́ctor Navarro
Rankless by CCL
2026